Tissue removal effect of tuttha in any type of ulcer with refferance of hypergranulation of wound
Phase 2
- Conditions
- Health Condition 1: L768- Other intraoperative and postprocedural complications of skin and subcutaneous tissue
- Registration Number
- CTRI/2023/02/049500
- Lead Sponsor
- Dr. Swapnil chavan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patient with classical sign & symptom of Hypergranulation and giving voluntary informed consent
Age - 18-70 years
Gender â?? Both
Wound size - 1-5 sq. cm ( using graph paper).
Exclusion Criteria
Patients with uncontrolled diabetes
Patients with infective pathology in hypergranulation.
Immunocompromised patients.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To observe complete resolution of Hypergranulation with tuttha kshar.Timepoint: Schedule once a day <br/ ><br>Duration 7 day <br/ ><br>Follow up 7,15,21 days
- Secondary Outcome Measures
Name Time Method To observe complete resolution of Hypergranulation with tuttha kshar.Timepoint: Schedule once a day <br/ ><br>Duration 7 day <br/ ><br>Follow up 7,15,21 days